Narrative therapy-assisted psilocybin use for treatment of depression
Faculty Sponsor(s)
Scott Edwards, Ph.D.
Presentation Type
Event
Primary Department
Marriage and Family Therapy
Description
There is recent renewed interest in use of psychedelic drugs for treatment of psychiatric disorders, including serotonin agonists such as psilocybin, potentially providing a new approach to treatment. I hypothesize use of psilocybin in conjunction with narrative therapy will produce a substantial impact on symptoms of depression. Using a true experimental design, I will compare the influence of therapy-assisted psilocybin to treat depression against a control group, therapy-only treatment, and psilocybin-only treatment over the course of two months. The Beck Depression Index will be used at the beginning and end of the trial, with regression used for data analysis
Copyright Status
http://rightsstatements.org/vocab/InC/1.0/
Additional Rights Information
Copyright held by author(s).
Narrative therapy-assisted psilocybin use for treatment of depression
There is recent renewed interest in use of psychedelic drugs for treatment of psychiatric disorders, including serotonin agonists such as psilocybin, potentially providing a new approach to treatment. I hypothesize use of psilocybin in conjunction with narrative therapy will produce a substantial impact on symptoms of depression. Using a true experimental design, I will compare the influence of therapy-assisted psilocybin to treat depression against a control group, therapy-only treatment, and psilocybin-only treatment over the course of two months. The Beck Depression Index will be used at the beginning and end of the trial, with regression used for data analysis
Rights Statement
